Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
ADVANCED MEDICAL TECHNOLOGY ASSN

2. Address

Address1
701 PENNSYLVANIA AVENUE, N.W., SUITE 800
 Address2
​
City
WASHINGTON
 State
DC
 Zip Code
20004
 Country
USA

3. Principal place of business (if different than line 2)

City
​
 State
​
 Zip Code
​
 Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​BRETT LOPER
​2024347242
​bloper@advamed.org
5. Senate ID#
​17831-12
7. Client Name Self Check if client is a state or local government or instrumentality
​ADVANCED MEDICAL TECHNOLOGY ASSN
6. House ID#
​310010000
TYPE OF REPORT 8. Year
​2010
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
 11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​358,264.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Senior Executive Vice President and Director, Government Affairs
 Date
10/20/2010

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 3590 (PL 111-148) - The Patient Protection and Affordable Care Act - issues related to the Patient-Centered Outcomes Research Institute. [Julie Cohen, Elizabeth Kegler, Elizabeth Sharp, Brett Loper]
H.R. 3590 (PL 111-148) - The Patient Protection and Affordable Care Act - issues related to Accountable Care Organizations. [Julie Cohen, Leah Kegler, Brett Loper]
Issues related to health care group purchasing organizations. [Julie Cohen, Brett Loper]

Issues related to healthcare-acquired infections in the Medicare Inpatient Prospective Payment rule. [Elizabeth Sharp]

Issues related to oversight of implantable devices. [Brett Loper, Julie Cohen, Elizabeth Kegler]

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Julie
Cohen
​
​
Brett
Loper
​
​
Elizabeth
Kegler
​
​
Elizabeth
Sharp
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

HR 1346/S.540 Medical Device Safety Act of 2009 - To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. [Elizabeth Sharp, Brett Loper, Elizabeth Kegler]

Issues related to the 510(k) process for medical devices. [Elizabeth Sharp, Brett Loper, Elizabeth Kegler, Julie Cohen]
Issues related to radiation therapy and imaging services. [Elizabeth Sharp, Elizabeth Kegler, Julie Cohen]

HR 5440 (Rep. Patrick Kennedy) - To secure the promise of personalized medicine for all Americans by expanding and accelerating genomics research and initiatives to improve the accuracy of disease diagnosis, increase the safety of drugs, and identify novel treatments and for other purposes. [Elizabeth Sharp]

Sen. Orrin Hatch draft BETTER Patient Care Act. To restructure how the FDA regulates certain advanced diagnostics [Brett Loper]

Rep. Jim Matheson and Rep. Steve Buyer drug pedigree bill. To establish a system of drug pedigree [Elizabeth Sharp]

Issues related to the competitiveness of the medical technology industry and the impact of Federal policies. [Julie Cohen, Elizabeth Sharp]

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elizabeth
Sharp
​
​
Brett
Loper
​
​
Julie
Cohen
​
​
Elizabeth
Kegler
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

FY11 Agriculture Appropriations bill [Elizabeth Sharp]

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Elizabeth
Sharp
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
 State
​
 Zip Code
​
 Country
​

21. Client new principal place of business (if different than line 20)

City
​
 State
​
 Zip Code
​
 Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6